Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Roots

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Journal of Geriatric Psychiatry and Neurology|October 1, 1994
Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteersB Staffeldt, R Kerb, J Brockmöller, et al.
Transplantation Proceedings|August 1, 1990
Activity of cyclosporin metabolites M17 and M1U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Archives of Toxicology|May 20, 1998
High frequency of CYP1A1 mutations in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
Cancer Research|August 1, 1994
Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control studyJ Brockmöller, R Kerb, N Drakoulis, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Theophylline metabolism affected by mexiletineK L Rost, U Fuhr, I Roots, et al.
Pharmacogenetics|February 18, 1999
Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquineC Sachse, J Brockmöller, M Hildebrand, et al.
Deutsche Medizinische Wochenschrift (1946)|May 11, 2004
[The Estonian Genome Project in the context of European genome research]A Metspalu, F Köhler, G Laschinski, et al.
Intensive Care Medicine|January 1, 1990
Clearance of ceftriaxone in critical care patients with acute renal failureG Heinemeyer, J Link, W Weber, et al.
Pharmacogenetics|August 1, 1997
Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humansS Fritz, W Lindner, I Roots, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Journal of Geriatric Psychiatry and Neurology|October 1, 1994
Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteersB Staffeldt, R Kerb, J Brockmöller, et al.
Transplantation Proceedings|August 1, 1990
Activity of cyclosporin metabolites M17 and M1U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Archives of Toxicology|May 20, 1998
High frequency of CYP1A1 mutations in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
Cancer Research|August 1, 1994
Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control studyJ Brockmöller, R Kerb, N Drakoulis, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Theophylline metabolism affected by mexiletineK L Rost, U Fuhr, I Roots, et al.
Pharmacogenetics|February 18, 1999
Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquineC Sachse, J Brockmöller, M Hildebrand, et al.
Deutsche Medizinische Wochenschrift (1946)|May 11, 2004
[The Estonian Genome Project in the context of European genome research]A Metspalu, F Köhler, G Laschinski, et al.
Intensive Care Medicine|January 1, 1990
Clearance of ceftriaxone in critical care patients with acute renal failureG Heinemeyer, J Link, W Weber, et al.
Pharmacogenetics|August 1, 1997
Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish populationA S Aynacioglu, I Cascorbi, P M Mrozikiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humansS Fritz, W Lindner, I Roots, et al.
Pageof 23